Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kah-Whye Peng

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 6, 2023
Oncolytic α-herpesvirus and myeloid-tropic cytomegalovirus cooperatively enhance systemic antitumor responsesHaifei Jiang, Rebecca Nace, Emily Ariail, et al.
Cancer Gene Therapy|March 5, 2005
Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancerRae Myers, Suzanne Greiner, Mary Harvey, et al.
Hypertension (Dallas, Tex. : 1979)|June 12, 2015
B-Type Natriuretic Peptide Deletion Leads to Progressive Hypertension, Associated Organ Damage, and Reduced Survival: Novel Model for Human HypertensionSara J Holditch, Claire A Schreiber, Ryan Nini, et al.
Plos One|September 17, 2013
Mathematical model for radial expansion and conflation of intratumoral infectious centers predicts curative oncolytic virotherapy parametersKent Bailey, Amber Kirk, Shruthi Naik, et al.
Journal of Translational Medicine|January 26, 2013
Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancerEmily K Mader, Greg Butler, Sean C Dowdy, et al.
Cancer Research|May 17, 2003
Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiformeLoi K Phuong, Cory Allen, Kah-Whye Peng, et al.
Journal of Virology|January 18, 2013
PEGylation of vesicular stomatitis virus extends virus persistence in blood circulation of passively immunized miceMulu Z Tesfay, Amber C Kirk, Elizabeth M Hadac, et al.
Journal of Chemical Information and Modeling|March 6, 2020
Mapping of Ion and Substrate Binding Sites in Human Sodium Iodide Symporter (hNIS)Hristina R Zhekova, Toshie Sakuma, Ryan Johnson, et al.
Frontiers in Oncology|July 12, 2017
Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most EffectiveDina Kleinlützum, Julia D S Hanauer, Alexander Muik, et al.
Head & Neck|October 12, 2013
Preclinical safety and activity of recombinant VSV-IFN-β in an immunocompetent model of squamous cell carcinoma of the head and neckVittal V S Kurisetty, Joshua Heiber, Rae Myers, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 6, 2023
Oncolytic α-herpesvirus and myeloid-tropic cytomegalovirus cooperatively enhance systemic antitumor responsesHaifei Jiang, Rebecca Nace, Emily Ariail, et al.
Cancer Gene Therapy|March 5, 2005
Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancerRae Myers, Suzanne Greiner, Mary Harvey, et al.
Hypertension (Dallas, Tex. : 1979)|June 12, 2015
B-Type Natriuretic Peptide Deletion Leads to Progressive Hypertension, Associated Organ Damage, and Reduced Survival: Novel Model for Human HypertensionSara J Holditch, Claire A Schreiber, Ryan Nini, et al.
Plos One|September 17, 2013
Mathematical model for radial expansion and conflation of intratumoral infectious centers predicts curative oncolytic virotherapy parametersKent Bailey, Amber Kirk, Shruthi Naik, et al.
Journal of Translational Medicine|January 26, 2013
Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancerEmily K Mader, Greg Butler, Sean C Dowdy, et al.
Cancer Research|May 17, 2003
Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiformeLoi K Phuong, Cory Allen, Kah-Whye Peng, et al.
Journal of Virology|January 18, 2013
PEGylation of vesicular stomatitis virus extends virus persistence in blood circulation of passively immunized miceMulu Z Tesfay, Amber C Kirk, Elizabeth M Hadac, et al.
Journal of Chemical Information and Modeling|March 6, 2020
Mapping of Ion and Substrate Binding Sites in Human Sodium Iodide Symporter (hNIS)Hristina R Zhekova, Toshie Sakuma, Ryan Johnson, et al.
Frontiers in Oncology|July 12, 2017
Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most EffectiveDina Kleinlützum, Julia D S Hanauer, Alexander Muik, et al.
Head & Neck|October 12, 2013
Preclinical safety and activity of recombinant VSV-IFN-β in an immunocompetent model of squamous cell carcinoma of the head and neckVittal V S Kurisetty, Joshua Heiber, Rae Myers, et al.
Pageof 12